NPI: 1336183367 · FARMINGTON HILLS, MI 48336 · General Acute Care Hospital · NPI assigned 06/16/2006
Authorized official COX, MATTHEW controls 20+ related entities in our dataset. Read more
| Authorized Official | COX, MATTHEW (CHIEF FINANCIAL OFFICER) |
| NPI Enumeration Date | 06/16/2006 |
Other providers sharing the same authorized official: COX, MATTHEW
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 217,388 | $8.57M |
| 2019 | 323,363 | $8.92M |
| 2020 | 295,577 | $8.49M |
| 2021 | 401,250 | $11.35M |
| 2022 | 398,499 | $11.79M |
| 2023 | 423,058 | $13.26M |
| 2024 | 346,235 | $9.84M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 61,788 | 57,632 | $19.35M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 37,320 | 36,243 | $6.86M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 100,252 | 90,578 | $5.88M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 30,043 | 29,139 | $3.72M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 35,502 | 32,772 | $3.31M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 16,971 | 11,314 | $1.64M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 9,308 | 6,102 | $1.48M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 12,659 | 12,449 | $1.02M |
| 96375 | Therapeutic injection; each additional sequential IV push | 30,399 | 25,109 | $982K |
| 71046 | Radiologic examination, chest; 2 views | 17,295 | 16,893 | $872K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 33,145 | 8,923 | $831K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6,391 | 6,287 | $824K |
| 93975 | 6,634 | 6,355 | $745K | |
| 80061 | Lipid panel | 49,538 | 49,351 | $706K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3,726 | 3,710 | $679K |
| 96361 | Intravenous infusion, hydration; each additional hour | 19,242 | 16,701 | $653K |
| 59025 | Fetal non-stress test | 7,200 | 3,751 | $633K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,826 | 1,816 | $614K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1,134 | 1,127 | $593K |
| G0378 | Hospital observation service, per hour | 6,532 | 5,920 | $593K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 31,609 | 31,112 | $580K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 5,886 | 4,839 | $578K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 31,372 | 30,883 | $576K |
| J9271 | Injection, pembrolizumab, 1 mg | 92 | 69 | $567K |
| 70450 | Computed tomography, head or brain; without contrast material | 6,833 | 6,685 | $524K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 9,777 | 9,549 | $468K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 6,163 | 6,014 | $461K |
| 82947 | 19,033 | 15,270 | $455K | |
| 76830 | Ultrasound, transvaginal | 7,045 | 6,932 | $420K |
| 71045 | Radiologic examination, chest; single view | 9,560 | 9,193 | $399K |
| 84443 | Thyroid stimulating hormone (TSH) | 50,030 | 49,472 | $377K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 25,510 | 25,416 | $374K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 7,685 | 7,672 | $370K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 7,534 | 7,406 | $357K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 294 | 275 | $341K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 23,934 | 6,793 | $337K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2,977 | 2,956 | $301K |
| 80053 | Comprehensive metabolic panel | 66,238 | 63,863 | $282K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 21,993 | 21,908 | $275K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 31,609 | 27,199 | $264K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 124,799 | 113,274 | $262K |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | 440 | 412 | $250K |
| 87480 | 21,791 | 21,505 | $237K | |
| 87660 | 21,536 | 21,267 | $233K | |
| 97162 | 4,069 | 4,043 | $223K | |
| 87510 | 20,913 | 20,641 | $222K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 10,077 | 8,873 | $215K |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 520 | 520 | $214K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1,570 | 1,568 | $212K |
| J2505 | Injection, pegfilgrastim, 6 mg | 138 | 106 | $209K |
| 76801 | 3,312 | 3,133 | $208K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 381 | 377 | $208K |
| 83036 | Hemoglobin; glycosylated (A1C) | 44,100 | 43,938 | $207K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 2,992 | 2,981 | $203K |
| 96415 | 4,217 | 3,301 | $202K | |
| 97161 | 1,975 | 1,959 | $194K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 9,329 | 9,227 | $181K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 2,269 | 2,231 | $175K |
| 94060 | 1,258 | 1,254 | $171K | |
| 96367 | 4,980 | 3,457 | $168K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 846 | 845 | $167K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 16,616 | 16,377 | $163K |
| 93970 | 1,777 | 1,758 | $162K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1,815 | 1,744 | $157K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,554 | 2,500 | $147K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 326 | 323 | $144K |
| 93350 | 752 | 751 | $143K | |
| 90651 | 1,012 | 1,004 | $138K | |
| 93971 | 2,612 | 2,573 | $132K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 4,257 | 2,956 | $131K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 13,054 | 12,581 | $128K |
| 76770 | 1,998 | 1,982 | $125K | |
| 96417 | 3,073 | 2,035 | $120K | |
| 76642 | 3,168 | 3,129 | $119K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 6,180 | 6,170 | $118K |
| 82607 | 16,984 | 16,888 | $114K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 46,888 | 42,401 | $112K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2,590 | 2,480 | $112K |
| 90686 | 6,479 | 6,469 | $111K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 7,459 | 7,450 | $104K |
| 86803 | 12,352 | 12,314 | $101K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 6,174 | 6,044 | $101K |
| 77066 | Tomosynthesis, mammo | 1,712 | 1,699 | $100K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 447 | 445 | $96K |
| 86900 | 11,012 | 10,416 | $94K | |
| 90750 | 620 | 615 | $86K | |
| 10060 | 990 | 967 | $82K | |
| J1453 | Injection, fosaprepitant, 1 mg | 2,399 | 1,606 | $80K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 843 | 843 | $80K |
| 76536 | 1,532 | 1,523 | $76K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1,426 | 1,368 | $70K |
| 90732 | 868 | 863 | $70K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 30,377 | 28,667 | $68K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 16,979 | 16,597 | $66K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,308 | 2,230 | $66K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 505 | 502 | $65K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 179 | 178 | $63K |
| 86780 | 7,559 | 7,500 | $62K | |
| 80074 | 2,696 | 2,676 | $62K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 14,104 | 10,372 | $60K |
| 74022 | 3,071 | 3,029 | $59K | |
| 82728 | 9,540 | 9,433 | $59K | |
| 97165 | 1,410 | 1,394 | $58K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 4,255 | 4,216 | $58K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2,610 | 2,589 | $57K |
| 70491 | 564 | 560 | $57K | |
| 84702 | 21,443 | 19,571 | $57K | |
| 87340 | 10,712 | 10,672 | $56K | |
| 70486 | 1,509 | 1,499 | $56K | |
| 77065 | Tomosynthesis, mammo | 1,289 | 1,235 | $55K |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 4,241 | 4,224 | $55K |
| 90670 | 627 | 621 | $52K | |
| 84466 | 8,758 | 8,671 | $52K | |
| 36415 | Collection of venous blood by venipuncture | 68,503 | 62,397 | $51K |
| 96411 | 1,427 | 927 | $51K | |
| 84439 | 11,705 | 11,578 | $51K | |
| 82746 | 7,248 | 7,199 | $47K | |
| 90677 | 183 | 182 | $42K | |
| 97166 | 1,019 | 1,006 | $42K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 7,361 | 7,090 | $41K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 3,183 | 3,181 | $41K |
| 73630 | 4,208 | 4,032 | $39K | |
| 74018 | 2,312 | 2,278 | $39K | |
| J0897 | Injection, denosumab, 1 mg | 127 | 126 | $38K |
| 71250 | 690 | 688 | $38K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 3,093 | 3,088 | $38K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 50 | 50 | $36K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 1,497 | 450 | $35K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 67 | 66 | $35K |
| 84481 | 3,989 | 3,953 | $34K | |
| 73562 | 1,929 | 1,844 | $34K | |
| 73130 | 3,096 | 2,995 | $34K | |
| 74019 | 1,560 | 1,545 | $34K | |
| 85027 | 15,770 | 14,111 | $33K | |
| 86235 | 1,436 | 1,283 | $33K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 533 | 527 | $32K |
| 96416 | 173 | 104 | $32K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 2,956 | 1,937 | $31K |
| 83735 | 31,463 | 26,029 | $31K | |
| 83540 | 9,792 | 9,697 | $30K | |
| 58558 | 24 | 24 | $30K | |
| 73610 | 3,043 | 2,935 | $30K | |
| 71271 | 511 | 511 | $29K | |
| 73030 | 2,569 | 2,476 | $28K | |
| 87653 | 1,743 | 1,724 | $28K | |
| 84403 | 1,923 | 1,911 | $28K | |
| 87631 | 7,603 | 7,481 | $27K | |
| 86592 | 9,832 | 9,790 | $27K | |
| 86769 | 1,473 | 1,470 | $26K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,422 | 2,390 | $26K |
| 87428 | 688 | 684 | $25K | |
| 82670 | 1,592 | 1,587 | $25K | |
| 93017 | 1,888 | 1,866 | $25K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 2,052 | 2,048 | $25K |
| 84153 | 2,891 | 2,880 | $25K | |
| 84460 | 10,243 | 9,892 | $24K | |
| 84450 | 10,758 | 10,399 | $24K | |
| 82565 | 10,181 | 9,891 | $23K | |
| 83001 | 2,268 | 2,264 | $23K | |
| 87186 | 4,976 | 4,895 | $21K | |
| 86696 | 1,921 | 1,912 | $21K | |
| 87077 | 4,732 | 4,641 | $20K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 285 | 283 | $19K |
| 20610 | 143 | 136 | $19K | |
| 73110 | 1,704 | 1,666 | $19K | |
| 82043 | 6,670 | 6,643 | $19K | |
| 88184 | 231 | 230 | $19K | |
| 99406 | 1,255 | 1,243 | $19K | |
| 80069 | 8,656 | 6,653 | $18K | |
| 86038 | 3,266 | 3,249 | $18K | |
| 83021 | 2,101 | 2,097 | $18K | |
| 90746 | 268 | 268 | $18K | |
| 87070 | 4,429 | 4,360 | $18K | |
| 83002 | 1,759 | 1,754 | $18K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 258 | 257 | $17K |
| 83970 | 829 | 810 | $17K | |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 37 | 26 | $17K |
| 96523 | 537 | 393 | $17K | |
| 86762 | 2,404 | 2,397 | $16K | |
| 84146 | 1,471 | 1,464 | $16K | |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 32 | 12 | $15K |
| 86160 | 1,613 | 1,580 | $15K | |
| 97014 | 1,881 | 627 | $15K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 255 | 250 | $15K |
| 72110 | 888 | 883 | $15K | |
| 73502 | 1,315 | 1,292 | $15K | |
| 82105 | 1,744 | 1,735 | $14K | |
| 80051 | 4,649 | 4,509 | $14K | |
| 86140 | 9,939 | 9,685 | $14K | |
| 83880 | 3,742 | 3,605 | $14K | |
| 86695 | 1,918 | 1,910 | $14K | |
| 90739 | 107 | 107 | $13K | |
| 86850 | 11,004 | 10,413 | $13K | |
| 84520 | 6,933 | 6,751 | $13K | |
| 86706 | 2,407 | 2,398 | $13K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 4,473 | 3,194 | $13K |
| 86480 | 364 | 361 | $12K | |
| 74183 | 64 | 64 | $12K | |
| 84402 | 794 | 792 | $11K | |
| 87147 | 2,721 | 2,657 | $11K | |
| 81003 | 28,732 | 27,720 | $11K | |
| 86225 | 1,872 | 1,857 | $10K | |
| 64450 | 80 | 78 | $10K | |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | 57 | 57 | $10K |
| 88307 | 174 | 173 | $10K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 78 | 77 | $10K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 392 | 383 | $10K |
| 81514 | 56 | 56 | $10K | |
| 81001 | 29,687 | 28,324 | $10K | |
| 84550 | 4,889 | 4,752 | $9K | |
| 84100 | 15,487 | 14,052 | $9K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 420 | 415 | $9K |
| 90671 | 60 | 60 | $9K | |
| 84478 | 714 | 700 | $9K | |
| 86003 | 170 | 169 | $9K | |
| 85652 | 8,226 | 8,072 | $9K | |
| 82784 | 1,031 | 1,018 | $9K | |
| 76377 | 1,124 | 1,104 | $8K | |
| 85610 | 18,562 | 17,141 | $8K | |
| 86200 | 1,540 | 1,531 | $8K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 846 | 397 | $8K |
| 82570 | 3,938 | 3,822 | $8K | |
| 82550 | 6,395 | 6,008 | $8K | |
| 80076 | 6,271 | 6,010 | $8K | |
| 73590 | 1,299 | 1,272 | $8K | |
| 72170 | 1,250 | 1,239 | $8K | |
| 93798 | 167 | 26 | $8K | |
| G0475 | Hiv antigen/antibody, combination assay, screening | 599 | 596 | $7K |
| 82248 | 12,321 | 11,324 | $7K | |
| 83690 | 16,944 | 15,964 | $7K | |
| 10061 | 36 | 36 | $7K | |
| 72141 | 50 | 50 | $7K | |
| 72100 | 315 | 312 | $7K | |
| 83013 | 214 | 214 | $7K | |
| 91322 | 51 | 50 | $7K | |
| 82950 | 2,757 | 2,734 | $7K | |
| J1750 | Injection, iron dextran, 50 mg | 254 | 111 | $7K |
| 83655 | 1,022 | 1,021 | $7K | |
| 82040 | 3,363 | 3,197 | $7K | |
| 86787 | 1,015 | 1,010 | $7K | |
| 82977 | 2,133 | 2,075 | $7K | |
| 73564 | 1,240 | 1,230 | $7K | |
| 82247 | 2,943 | 2,413 | $7K | |
| 86431 | 2,378 | 2,371 | $6K | |
| 87634 | 123 | 121 | $6K | |
| 87529 | 242 | 242 | $6K | |
| 90734 | 202 | 196 | $6K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1,307 | 1,286 | $6K |
| 81025 | 15,266 | 14,815 | $6K | |
| 85730 | 15,398 | 14,491 | $5K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 49 | 49 | $5K |
| 99495 | 82 | 82 | $5K | |
| G0008 | Administration of influenza virus vaccine | 761 | 754 | $5K |
| 99385 | 74 | 74 | $5K | |
| 80305 | 1,118 | 1,097 | $5K | |
| 97116 | 633 | 345 | $5K | |
| 82150 | 2,224 | 2,149 | $5K | |
| 73090 | 793 | 763 | $5K | |
| 88304 | 1,763 | 1,746 | $5K | |
| 87632 | 65 | 65 | $5K | |
| 83615 | 2,189 | 2,052 | $5K | |
| 36430 | 29 | 24 | $5K | |
| 82627 | 328 | 327 | $4K | |
| 76870 | 269 | 267 | $4K | |
| 90656 | 235 | 234 | $4K | |
| 86704 | 651 | 647 | $4K | |
| 87205 | 2,327 | 2,268 | $4K | |
| 85046 | 1,927 | 1,836 | $4K | |
| 86901 | 10,659 | 10,076 | $4K | |
| 84075 | 1,547 | 1,416 | $4K | |
| 88342 | 344 | 338 | $4K | |
| 64415 | 79 | 78 | $4K | |
| 82785 | 428 | 401 | $4K | |
| M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | 34 | 34 | $4K |
| 83516 | 500 | 497 | $4K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 13 | 13 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4,049 | 4,005 | $3K |
| 72131 | 75 | 75 | $3K | |
| 86162 | 311 | 309 | $3K | |
| 90480 | 68 | 67 | $3K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 37 | 37 | $3K |
| 87536 | 53 | 53 | $3K | |
| 73140 | 211 | 205 | $2K | |
| 80050 | General health panel | 464 | 462 | $2K |
| 72197 | 12 | 12 | $2K | |
| 93880 | 26 | 26 | $2K | |
| 84156 | 1,690 | 1,579 | $2K | |
| 81002 | 1,521 | 1,513 | $2K | |
| 82533 | 381 | 360 | $2K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 33 | 33 | $2K |
| 99496 | 36 | 36 | $2K | |
| 64400 | 15 | 14 | $2K | |
| 93225 | 39 | 39 | $2K | |
| 74178 | 12 | 12 | $2K | |
| 87109 | 296 | 291 | $2K | |
| 86039 | 363 | 362 | $2K | |
| 87075 | 644 | 626 | $2K | |
| 84155 | 1,124 | 995 | $2K | |
| 84165 | 373 | 369 | $2K | |
| 85379 | 5,260 | 5,146 | $2K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 24 | 24 | $2K |
| 82652 | 111 | 111 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 11,359 | 10,498 | $2K |
| 72040 | 221 | 220 | $2K | |
| 93308 | 15 | 14 | $2K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 2,809 | 2,650 | $2K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 52 | 42 | $1K |
| 76881 | 24 | 24 | $1K | |
| 86376 | 192 | 192 | $1K | |
| 94010 | 71 | 66 | $1K | |
| 96376 | 6,318 | 4,452 | $1K | |
| 84144 | 101 | 100 | $1K | |
| 76942 | 2,162 | 2,142 | $1K | |
| 77336 | 21 | 12 | $1K | |
| 73070 | 103 | 99 | $1K | |
| 87522 | Neg quan hep c or qual rna | 57 | 55 | $1K |
| 84484 | 16,876 | 13,491 | $1K | |
| 73080 | 176 | 173 | $1K | |
| 76818 | 18 | 12 | $1K | |
| 86360 | 43 | 43 | $1K | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 24 | 24 | $1K |
| 86580 | 200 | 194 | $1K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 73 | 73 | $999.81 |
| 96127 | 157 | 154 | $987.49 | |
| 97035 | 186 | 72 | $981.05 | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16 | 14 | $976.24 |
| 88142 | 90 | 90 | $971.96 | |
| 87210 | 2,348 | 2,291 | $893.72 | |
| 86147 | 25 | 25 | $855.17 | |
| 86359 | 43 | 43 | $826.67 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 558 | 558 | $813.12 |
| 88143 | 71 | 71 | $810.58 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 4,953 | 3,932 | $800.00 |
| 73560 | 212 | 210 | $772.64 | |
| 82310 | 384 | 381 | $770.65 | |
| 70498 | 26 | 26 | $750.85 | |
| 11721 | 54 | 54 | $735.17 | |
| 86705 | 132 | 131 | $722.53 | |
| C1729 | Catheter, drainage | 271 | 253 | $700.00 |
| 77080 | 12 | 12 | $660.80 | |
| 94726 | 1,040 | 1,037 | $638.36 | |
| 83550 | 235 | 228 | $636.31 | |
| 73060 | 176 | 175 | $622.72 | |
| 84238 | 46 | 46 | $587.18 | |
| G0010 | Administration of hepatitis b vaccine | 40 | 40 | $581.66 |
| 86146 | 25 | 25 | $580.22 | |
| 87808 | 507 | 494 | $519.89 | |
| 97163 | 12 | 12 | $505.82 | |
| 90662 | 40 | 39 | $504.38 | |
| 89051 | 188 | 181 | $491.70 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 31 | 31 | $456.49 |
| 71101 | 134 | 132 | $440.35 | |
| 12001 | 713 | 708 | $409.95 | |
| 87040 | 2,066 | 1,871 | $375.65 | |
| 73120 | 18 | 12 | $340.70 | |
| 0003A | 13 | 13 | $337.77 | |
| 86923 | 68 | 65 | $324.65 | |
| 84134 | 71 | 66 | $302.40 | |
| 83605 | 10,411 | 9,358 | $299.87 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 64 | 59 | $297.11 |
| 82465 | 99 | 99 | $288.15 | |
| 82140 | 901 | 821 | $285.81 | |
| 85018 | 437 | 409 | $267.84 | |
| 84703 | 8,765 | 8,430 | $252.84 | |
| 97012 | 43 | 12 | $231.80 | |
| 96377 | 79 | 57 | $228.90 | |
| 86364 | 39 | 39 | $196.82 | |
| 72070 | 27 | 27 | $195.15 | |
| 70496 | 12 | 12 | $191.52 | |
| 82378 | 29 | 26 | $190.05 | |
| 86308 | 823 | 815 | $181.74 | |
| 84145 | 745 | 724 | $173.44 | |
| 94760 | 3,064 | 1,901 | $166.50 | |
| 97535 | Self-care/home management training, each 15 minutes | 34 | 26 | $156.64 |
| 82044 | 72 | 71 | $154.82 | |
| G0009 | Administration of pneumococcal vaccine | 13 | 13 | $145.17 |
| 82805 | 1,907 | 1,785 | $145.03 | |
| 82962 | 3,213 | 2,487 | $128.79 | |
| 80164 | 57 | 53 | $128.35 | |
| 82677 | 13 | 13 | $112.50 | |
| 12011 | 182 | 182 | $110.05 | |
| 29125 | 83 | 83 | $107.98 | |
| 86765 | 15 | 14 | $94.90 | |
| 73552 | 111 | 110 | $92.91 | |
| 12002 | 177 | 177 | $89.46 | |
| 83014 | 17 | 17 | $87.14 | |
| 82010 | 2,000 | 1,872 | $86.51 | |
| 85045 | 36 | 36 | $84.70 | |
| 82077 | 428 | 382 | $81.07 | |
| 86336 | 13 | 13 | $72.51 | |
| 83993 | 12 | 12 | $69.40 | |
| 94618 | 13 | 13 | $64.79 | |
| 84132 | 193 | 176 | $56.67 | |
| 70360 | 12 | 12 | $48.33 | |
| 83930 | 299 | 287 | $45.27 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 3,772 | 3,056 | $38.33 |
| 90474 | 12 | 12 | $36.00 | |
| 98925 | 15 | 15 | $31.88 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 34,806 | 32,142 | $24.44 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 680 | 668 | $23.68 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 19,051 | 15,776 | $22.36 |
| J2704 | Injection, propofol, 10 mg | 13,141 | 12,833 | $22.22 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 7,087 | 5,413 | $21.26 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 14,794 | 12,435 | $19.45 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 7,779 | 6,869 | $18.22 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 24,564 | 21,523 | $17.60 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 11,382 | 9,575 | $14.27 |
| J1790 | Injection, droperidol, up to 5 mg | 902 | 816 | $13.41 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 1,839 | 1,801 | $12.07 |
| 85014 | 25 | 25 | $11.82 | |
| J3480 | Injection, potassium chloride, per 2 meq | 1,127 | 642 | $10.62 |
| 80179 | 528 | 496 | $10.20 | |
| 80143 | 535 | 502 | $10.20 | |
| J1644 | Injection, heparin sodium, per 1000 units | 7,250 | 3,829 | $7.04 |
| 88300 | 63 | 63 | $6.39 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 3,314 | 3,077 | $5.55 |
| 85384 | 92 | 85 | $5.23 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 1,810 | 828 | $2.29 |
| J0690 | Injection, cefazolin sodium, 500 mg | 5,825 | 5,018 | $1.91 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 3,164 | 2,430 | $1.68 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 14 | 12 | $0.20 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 1,178 | 1,122 | $0.02 |
| 90714 | 2,149 | 2,144 | $0.00 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 124 | 123 | $0.00 |
| J1953 | Injection, levetiracetam, 10 mg | 189 | 148 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 466 | 358 | $0.00 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 198 | 191 | $0.00 |
| 90715 | 2,520 | 2,508 | $0.00 | |
| 94729 | 1,034 | 1,032 | $0.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 5,095 | 4,677 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 120 | 90 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 214 | 213 | $0.00 |
| J0640 | Injection, leucovorin calcium, per 50 mg | 568 | 231 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 4,414 | 3,581 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 31 | 30 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 2,682 | 1,801 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 1,792 | 1,768 | $0.00 |
| J1756 | Injection, iron sucrose, 1 mg | 2,898 | 1,253 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 681 | 604 | $0.00 |
| J9190 | Injection, fluorouracil, 500 mg | 1,228 | 372 | $0.00 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 44 | 43 | $0.00 |
| 90633 | 51 | 50 | $0.00 | |
| 99173 | 63 | 61 | $0.00 | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 874 | 866 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 979 | 962 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 50 | 45 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 182 | 176 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 459 | 407 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 1,657 | 1,446 | $0.00 |
| 58340 | 17 | 12 | $0.00 | |
| 3078F | 46 | 39 | $0.00 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 296 | 163 | $0.00 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 12 | 12 | $0.00 |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion | 16 | 12 | $0.00 |
| 91300 | 84 | 82 | $0.00 | |
| 90707 | 12 | 12 | $0.00 | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 88 | 51 | $0.00 |
| J0736 | Injection, clindamycin phosphate, 300 mg | 42 | 30 | $0.00 |
| Q0245 | Injection, bamlanivimab and etesevimab, 2100 mg | 100 | 57 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 202 | 154 | $0.00 |
| G0390 | Trauma response team associated with hospital critical care service | 12 | 12 | $0.00 |
| J2800 | Injection, methocarbamol, up to 10 ml | 27 | 25 | $0.00 |
| 76000 | 14 | 14 | $0.00 | |
| Q0239 | Injection, bamlanivimab-xxxx, 700 mg | 34 | 34 | $0.00 |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | 19 | 14 | $0.00 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 2,483 | 1,943 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 2,486 | 2,244 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 6,614 | 6,238 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 1,199 | 1,186 | $0.00 |
| J3360 | Injection, diazepam, up to 5 mg | 1,496 | 1,431 | $0.00 |
| A9270 | Non-covered item or service | 538 | 136 | $0.00 |
| 96368 | 960 | 633 | $0.00 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 472 | 445 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 4,434 | 3,045 | $0.00 |
| 97010 | 6,131 | 1,988 | $0.00 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 75 | 75 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 717 | 704 | $0.00 |
| J3411 | Injection, thiamine hcl, 100 mg | 353 | 280 | $0.00 |
| 64488 | 160 | 159 | $0.00 | |
| 36416 | 59 | 57 | $0.00 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 561 | 494 | $0.00 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 340 | 188 | $0.00 |
| 94761 | 500 | 426 | $0.00 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 335 | 243 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 1,571 | 852 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 1,011 | 600 | $0.00 |
| 90632 | 162 | 161 | $0.00 | |
| J9045 | Injection, carboplatin, 50 mg | 266 | 170 | $0.00 |
| 3074F | 120 | 108 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 28 | 27 | $0.00 |
| 91305 | 45 | 45 | $0.00 | |
| A9573 | Injection, gadopiclenol, 1 ml | 223 | 221 | $0.00 |
| J1836 | Injection, metronidazole, 10 mg | 130 | 73 | $0.00 |
| J7999 | Compounded drug, not otherwise classified | 229 | 220 | $0.00 |
| A4648 | Tissue marker, implantable, any type, each | 25 | 25 | $0.00 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 1,006 | 315 | $0.00 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 347 | 143 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 377 | 348 | $0.00 |
| J3490 | Unclassified drugs | 549 | 527 | $0.00 |
| 84270 | 26 | 25 | $0.00 | |
| J9267 | Injection, paclitaxel, 1 mg | 38 | 24 | $0.00 |
| 90680 | 37 | 37 | $0.00 | |
| 90698 | 38 | 38 | $0.00 | |
| C1769 | Guide wire | 127 | 125 | $0.00 |
| C1781 | Mesh (implantable) | 12 | 12 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 15 | 12 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 13 | 12 | $0.00 |
| 80320 | 18 | 12 | $0.00 | |
| J3410 | Injection, hydroxyzine hcl, up to 25 mg | 14 | 14 | $0.00 |